[1] Simon I,Zhuo S,Corral L,et al. B7-H4 is a novel membranebound protein and a candidate serum and tissue biomarker for ovarian cancer[J]. Cancer res, 2006,6 6(3): 1570-1575.
[2] Sun Y,Wang Y,Zhao J, et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer[J]. Lung Cancer,2006,53 (2 ): 143-151.
[3] Krambeck AE,Thompson rH,Dong H, et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival[J]. Proc Natl Acad Sci U S A, 2006,1 03(27): 10391-10396.
[4] Miyatake T,Tringler B,Liu W,et al. B7-H4 (DD-O110 ) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration [J]. Gynecol Oncol,2007,1 06(1): 119-127.
[5] Awadallah NS,Shroyer Kr,Langer DA, et al. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct[J]. Pancreas, 2008,3 6(2): 200-206.
[6] Choi IH,Zhu G,Sica GL,et al. Genomic organization and expression analysis of B7-H4,an immune inhibitory molecule of the B7 family[J]. J Immunol,2003, 171(9): 4650-4654.
[7] Kryczek I,Wei S,Zhu G,et al. relationship between B7-H4, regulatory T cells,and patient outcome in human ovarian carcinoma[J]. Cancer res,2007,6 7(18): 8900-8905.
[8] Suh WK,Wang S,Duncan G, et al. Generation and characterization of B7-H4/B7S1/B7x-deficient mice[J]. Mol Cell Biol,2006, 26(17): 6403-6411.
[9] Simon I,Katsaros D,rigault de la longrais I, et al. B7-H4 is overexpressed in early-stage ovarian cancer and is independent of CA125 expression[J]. Gynecol Oncol,2007,106 (2 ): 334-341.
[10] 王小梅,胡国艳,刘伟,等. 血液系统恶性肿瘤患者血清可溶 性B7-H4 的检测及其临床意义[J]. 细胞与分子免疫学杂志, 2010, 160(9): 893-897.
[11] 孙玉萍,刘杰,崔霞,等. B7-H4 在结直肠癌组织中表达的临 床意义[J]. 山东大学学报: 医学版,2 006,44(6): 590-592.